# What happened On June 1, 2026 New Scientist published a piece by Alice Klein that questioned the health benefits of turmeric (Curcuma longa) extracts and advised caution because of possible liver concerns. The article cited a paper that linked turmeric to three cases of clinically apparent liver injury and quoted language suggesting turmeric appears to be a leading cause of herbal-related liver injury in the United States.
# Why ABC objected Council (ABC) sent a letter to the editor criticizing the New Scientist article for not discussing established human clinical evidence supporting turmeric and its extracts. ABC said the article omitted numerous human clinical studies and systematic reviews that document benefits in areas such as knee osteoarthritis and metabolic syndrome.
# The core factual points in dispute
- Claim in New Scientist: turmeric "appears to have become the most common cause of clinically apparent, herbal-related liver injury in the United States." The magazine cited a paper that reported three cases.
- ABC's position: the New Scientist piece presented the hepatotoxic risk in a way that suggests a higher incidence than available data support and failed to present documented therapeutic evidence.
# What ABC offered in its response ABC sent a letter to the editor and included consumption-based data intended to put the reported hepatotoxic cases in context. ABC concluded that, taken together with real-world consumption figures, turmeric and its extracts present an extremely low risk of liver injury. ABC also emphasized that the article missed an opportunity to give readers a balanced account of both benefits and safety concerns.
# Practical implications for readers
# Where to look next ABC referenced HerbalGram (www.herbalgram.org) for additional material. The original New Scientist article and the paper it cited remain the direct sources for the case reports and the phrasing about herbal-related liver injury.
# Bottom line This is a dispute about framing and context: New Scientist emphasized liver-safety reports tied to turmeric extracts, while ABC objects that the article did not also present the body of human clinical evidence for benefits nor consumption-based data that show hepatotoxic events to be very rare.